Article
p53 transactivation and the impact of mutations, cofactors and small molecules using a simplified yeast-based screening system.
PloS one - 1 Jan 2011
Andreotti Virginia, Ciribilli Yari, Monti Paola, Bisio Alessandra, Lion Mattia, Jordan Jennifer, Fronza Gilberto, Menichini Paola, Resnick Michael A, Inga Alberto
Abstract excerpt
BACKGROUND: The p53 tumor suppressor, which is altered in most cancers, is a sequence-specific transcription factor that is able to modulate the expression of many target genes and influence a variety of cellular pathways. Inactivation of the p53 pathway in cancer frequently occurs through the expression of mutant p53 protein. In tumors that retain wild type p53, the pathway can be altered by upstream modulators,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
